Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: Amlodipine vs. ARB in atherosclerosis study)

Diabetes Research and Clinical Practice

Volumn 83, Issue 1, 2009, Pages 50-53

  Ikeda, Hiroki ^a,d   Minamikawa, Jun ^b   Nakamura, Yoshio ^c,d   Honjo, Sachiko ^a   Hamamoto, Yoshiyuki ^a,d   Wada, Yoshiharu ^a   Nabe, Kouichiro ^a   Koshiyama, Hiroyuki ^a,d  

^a Kitano Hospital   (Japan)

^b Minamikawa Clinic   (Japan)

^c HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Amlodipine; Angiotensin receptor blockers (ARB); Intima media thickness of carotid arterial wall

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; LOSARTAN; TELMISARTAN; VALSARTAN;

AGED; ARTERIAL WALL THICKNESS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

AGED; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 57949117221     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.10.014     Document Type: Article

References (27)

1. McMurray H.F., and Chahwala S.B. Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture. J. Cardiovasc. Pharmacol. 20 Suppl. A (1992) S54-S56
2. Jackson C.L., Bush R.C., and Bower D.E. Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis 80 (1989) 17-26
3. Munro E., Patel M., Chan P., Betteridge L., Gallagher K., Schachter M., et al. Effect of calcium channel blockers on the growth of human vascular smooth muscle cell derived from saphenous vein and vascular graft stenoses. J. Cardiovasc. Pharmacol. 23 (1994) 779-784
4. Block L.H., Matthys H., Emmons L.R., Perruchoud A., Erne P., Roth M., et al. Ca channel blockers modulate expression of expression of 3-hydroxy-3-methylgultaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9041-9045
5. Nayer W. The antiatherogenic effects of amlodipine. J. Cardiovasc. Pharmacol. 20 Suppl. A (1992) S51-S53
6. Beer N.A., Jakubowicz D.J., Beer R.M., Nestler J.E., et al. The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. J. Clin. Endocrinol. Metab. 76 (1993) 1464-1469
7. Koshiyama H., Tanaka S., and Minamikawa J. Effect of calcium channel blocker amlodipine on intimal-medial thickness of carotid artery in type 2 diabetes. J. Cardiovasc. Pharmcol. 33 (1999) 894-896
8. Pitt B., Byington R.P., Furberg C.D., Hunninghake D.B., Mancini G.B., Miller M.E., et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 102 (2000) 1503-1510
9. Stanton A.V., Chapman J.N., Mayet J., Sever P.S., Poulter N.R., Hughes A.D., et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin. Sci. 101 (2001) 455-464
10. Terpstra W.F., May J.F., Smit A.J., Graeff P.A., and Meyboom-de Jong B. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J. Hypertens. 22 (2004) 1309-1316
11. Minamikawa J., Yamauchi M., Tanaka S., and Koshiyama H. Carotid arterial intimal-medial thickening and plaque formation in NIDDM. Diabetes Care 21 (1998) 323-324
12. Minamikawa J., Tanaka S., Yamauchi M., Inoue D., and Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J. Clin. Endocrinol. Metab. 83 (1998) 1818-1820
13. Koshiyama H., Shimono D., Kuwamura N., Minamikawa J., and Nakamura Y. Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J. Clin. Endocrinol. Metab. 86 (2001) 3452-3456
14. Kalinowski L., Matys T., Chabielska E., Buczko W., and Malinski T. Angiotensin II AT1 receptor antagonists inhibit platlet adhesion and aggregation by nitric oxide release. Hypertension 40 (2002) 521-527
15. Candido R., Allen T.J., Lassila M., Cao Z., Thallas V., Cooper M.E., et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109 (2004) 1536-1542
16. Takai S., Jin D., Sakaguchi M., Muramatsu M., and Miyazaki M. The regressive effect of an angiotensin II receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet. J. Hypertens. 23 (2005) 1879-1886
17. Koshiyama H., Nakamura Y., Tanaka S., and Minamikawa J. Decrease in carotid intima-media thickness after one-year therapy with etidronate for osteopenia associated with type 2 diabetes. J. Clin. Endocrinol. Metab. 85 (2000) 2793-2796
18. Julius S., Kjeldsen S.E., Weber M., Brunner H.R., Ekman S., Hansson L., et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 363 (2004) 2022-2031
19. Wang J.-G., Staessen J.A., Li Y., Van Bortel L.M., Nawrot T., Fagard R., et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trial. Stroke 37 (2006) 1933-1940
20. Benson S.C., Pershadsingh H.A., Ho C.I., Chittiboyina A., Desai P., Pravenec M., et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ modulating activity. Hypertension 43 (2004) 993-1002
21. Honjo S., Nishi Y., Hamamoto Y., and Koshiyama H. Possible beneficial effect of telmisartan on glycemic control in diabetic subjects. Diabetes Care 28 (2005) 498 (letter)
22. Langenfeld M.R., Forst T., Hohberg C., Kann P., Lübben G., Konrad T., et al. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation 111 (2005) 2525-2531
23. Godfraind T. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 360 1464 (2005) 2259-2272
24. Xhang X., and Hintze T.H. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 95 (1998) 576-580
25. Ikeda U., Hojo Y., Ueno S., Arakawa H., and Shimada K. Amlodipine inhibits expression of matrix-metalloproteinase-1 and its inhibitor in human vascular endothelial cells. J. Cardiovasc. Pharmacol. 35 (2000) 887-890
26. 2+ channel blockers to the membrane lipid bilayer. Mol. Pharmacol. 41 (1992) 315-321
27. Nissen S.E., Tuzcu E.M., Libby P., Thompson P.D., Ghali M., Garza D., et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292 (2004) 2217-2225